Biosimilars: what clinicians should know.

Weise, Martina; Bielsky, Marie-Christine; De Smet, Karen; Ehmann, Falk; Ekman, Niklas; J Giezen, Thijs; Gravanis, Iordanis; Heim, Hans-Karl; Heinonen, Esa; Ho, Kowid; Moreau, Alexandre; Narayanan, Gopalan; A Kruse, Nanna; Reichmann, Gabriele; Thorpe, Robin; van Aerts, Leon; Vleminckx, Camille; Wadhwa, Meenu; K Schneider, Christian

doi:10.1182/blood-2012-04-425744

Public

Biosimilars: what clinicians should know.

Shared by NobleBlocks on Dec 20, 2012 • 12:00 AM UTC

Authors:

Martina Weise

Marie-Christine Bielsky

Karen De Smet

Abstract

Biosimilar medicinal products (biosimilars) have become a reality in the European Union and will soon be available in the United States. Despite an established legal pathway for biosimilars in the European Union since 2005 and increasing and detailed regulatory guidance on data requirements for thei...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!